Disease Group: Frontotemporal dementia
Neuropsychological assessment in primary progressive aphasia – recommendations and pitfalls in clinical practice
Frontotemporal dementia vs. primary psychiatric disorders
Non-pharmacological approaches to treatment in svPPA
FTD- in whom, when and how genetic testing should be applied
Use of Biomarkers to monitor the presymptomatic phase of Genetic FTD: research advances for clinical trial readiness
22 Nov. 2022
Speaker: Harro Seelaar & Dario Saracino
Erasmus University Medical Center, Rotterdam, Netherlands;
APHP – Pitié-Salpêtrière Hospital, Paris, France
Telerehabilitation in RND: an update
Tau-targeting Therapies: Where are we heading to?
The logopenic variant of primary progressive aphasia (lvPPA): language, cognitive, neuroradiological issues’
5 Apr. 2022
Speaker: Robert Rusina & Zsolt Cséfalvay
Thomayer Hospital, Prague, Czech Republic; Comenius University in Bratislava, Slovakia
The overlap between the spectrum of frontotemporal dementias and atypical Parkinsonism
Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting
Functional gait disorders: a sign-based approach
Gene therapy in neuromuscular and mitochondrial disorders
Better Conversations – Communication Partner Training for language led dementias
Challenges in Frontotemporal Dementia: clinical, genetic and pathological heterogeneity
23 Mar. 2021
Speaker: Harro Seelaar
Erasmus University Medical Center, Rotterdam, Netherlands
Functional movement disorders: a diagnostic guide
How can we develop and implement evidence based rehabilitation in rare disorders?
29 Sep. 2020
Speaker: Hortensia Gimeno
Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
How to assess and manage spastic gait in rare diseases
Semantic variant of primary progressive aphasia
Goal setting and outcome measures of interventions in pediatric rehabilitation.
18 Jun. 2020
Speaker: Annemieke Buizer
VU University Medical Center Amsterdam, Netherlands;
Emma Children’s Hospital, Amsterdam, Netherlands